Xenon Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-06-30 | 2024-03-31 | 2023-12-31 |
|---|---|---|---|
Revenue | $0 | $0 | $5,380 |
Gross Profit | -659 | -599 | 4,529 |
EBITDA | -68,445 | -58,442 | -52,844 |
EBIT | -69,104 | -59,041 | -53,695 |
Net Income | -57,924 | -47,931 | -44,743 |
Net Change In Cash | 0 | 0 | 5,380 |
Free Cash Flow | -34,193 | -43,366 | -33,691 |
Cash | 136,734 | 58,896 | 148,643 |
Basic Shares | 77,671 | 77,594 | 69,968 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $0 | $9,434 | $18,437 | $32,166 |
Gross Profit | -167,512 | 9,434 | 18,437 | 32,166 |
EBITDA | -210,513 | -127,519 | -78,087 | -30,657 |
EBIT | -214,054 | -129,143 | -78,993 | -31,301 |
Net Income | -182,393 | -125,373 | -78,882 | -28,837 |
Net Change In Cash | 0 | 9,434 | 18,437 | 32,166 |
Cost of Revenue | -115,962 | 131,271 | 20,847 | |
Free Cash Flow | -150,944 | -101,324 | -71,552 | -50,761 |
Cash | 148,643 | 57,242 | 175,688 | 45,009 |
Basic Shares | 66,889 | 60,542 | 43,627 | 34,542 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-09-30 | -$0.81 |
2024-06-30 | -$0.75 |
2024-03-31 | -$0.62 |
2023-12-31 | -$0.64 |
